Training

Register now

Virtual meeting

Via Zoom

Description

Advanced Practice Practitioners (APPs) must complete 24 hours of specialized training to obtain a waiver to prescribe buprenorphine—an eight-hour Medication for Opioid Use Disorder (MOUD) X-Waiver waiver training course plus an additional 16 hours of training. Until now, the additional 16 hours has primarily been available through online, pre-recorded modules.

Boston Medical Center’s OBAT TTA is proud to announce a new no-cost, live training series that will provide APPs the additional 16 hours to meet these requirements. This training was developed by and for APPs.

The 3rd session in this series is titled "Medications for OUD and Addressing Polysubstance Use." It will be offered on May 20th, 2021 from 7am-9am ET. 

Intended audience

Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants

Speakers

Karen Haessler, PA Charmaine Lastimoso, MPH, MSN, NP-C, CARN-AP

Objectives

Participants will be able to:

• Explain the rationale for using medications to treat opioid use disorder. 
• Identify three evidence-based medications for treating opioid use disorder.
• Compare/contrast unique properties of methadone, buprenorphine, and naltrexone.
• List three examples of nicotine replacement therapy (NRT) for the treatment of tobacco use disorder. 
• Identify at least three signs and symptoms of benzodiazepine and alcohol withdrawal syndromes. 
• Recognize at least three hallmark signs and symptoms of “over-amping,” or stimulant overdose.

Sponsored by

Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Office Based Addiction Treatment and Technical Assistance (BMC OBAT TTA).

American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information, visit www.pcssNOW.org

Accreditation information

ACCME Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Boston University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Register now